Enhancing Hepatitis C Virus Testing, Linkage to Care, and Treatment Commencement in Hospitals: A Systematic Review and Meta-analysis - Scorecard - MDSpire
Advertisement
Enhancing Hepatitis C Virus Testing, Linkage to Care, and Treatment Commencement in Hospitals: A Systematic Review and Meta-analysis
Clinical Scorecard: Improving Testing, Care Connection, and Treatment Initiation for Hepatitis C Virus in Hospital Settings: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Hepatitis C Virus (HCV) infection
Key Mechanisms
Hospital-led interventions including automated opt-out antibody testing, reflex RNA testing, care coordination, and financial incentives to increase HCV testing uptake, linkage to care, and treatment initiation
Target Population
Hospital patients including inpatients, outpatients, and emergency department attendees, especially those with risk factors such as injecting drug use or birth cohort 1945–1965
Care Setting
Hospital settings including inpatient units, outpatient clinics, and emergency departments
Key Highlights
Hospital-led interventions significantly increase HCV antibody testing uptake (pOR 5.83) and RNA testing uptake (pOR 10.65) compared to usual care.
Automated opt-out antibody testing and reflex RNA testing show the greatest increases in testing uptake.
Care coordination and financial incentives improve linkage to care but no intervention consistently increases uptake across all care cascade steps.
Guideline-Based Recommendations
Diagnosis
Implement automated opt-out HCV antibody testing in hospital settings to increase testing rates.
Use reflex RNA testing following positive antibody tests to confirm active infection efficiently.
Management
Incorporate care coordination and financial incentives to enhance linkage to HCV care after diagnosis.
Explore additional interventions to improve treatment initiation as current strategies have limited impact on this step.
Monitoring & Follow-up
Track HCV testing uptake, linkage to care, and treatment initiation rates within hospital settings to evaluate intervention effectiveness.
Risks
Missed opportunities for diagnosis and treatment occur when HCV testing is not routinely offered despite risk factors.
Failure to link diagnosed patients to care and treatment limits the impact of testing interventions.
Patient & Prescribing Data
Hospitalized patients and those attending outpatient clinics or emergency departments with risk factors for HCV
Direct-acting antiviral (DAA) treatment initiation during hospitalization is uncommon; interventions increasing testing do not necessarily increase treatment uptake, indicating a need for focused linkage strategies.
Clinical Best Practices
Adopt automated opt-out antibody testing protocols in hospital settings to maximize diagnosis rates.
Utilize reflex RNA testing to streamline confirmation of active HCV infection.
Implement care coordination programs and consider financial incentives to improve linkage to care.
Recognize that multi-step interventions are needed as no single approach improves all steps of the HCV care cascade.
Prioritize interventions targeting linkage to treatment after diagnosis to achieve HCV elimination goals.